Arcadia Biosciences (RKDA) Misses Q4 EPS by 2c
Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07).
For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.
Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07).
For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.